Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00356668 · ClinicalTrials.gov registry record · Phase 3
Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure
A Phase 3 study, sponsored by Children's Hospitals and Clinics of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 16
- Enrollment target
NCT00356668 is a Phase 3 study that has completed, run by Children's Hospitals and Clinics of Minnesota. The registered enrollment target is 16 participants.
The verdict
NCT00356668, a Phase 3 study, has completed, sponsored by Children's Hospitals and Clinics of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 16 participants
- Enrollment target
Study Summary
The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distending pressure, gas flow, oxygen requirement, and patient weight, and lastly, develop an appropriate protocol to be used in the NICU for transitioning patients from NCPAP to an equivalent amount of HFNC.
Interventions
- DEVICE High Flow Nasal Cannula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00356668
The ClinicalTrials.gov registry entry for NCT00356668 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospitals and Clinics of Minnesota, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which High Flow Nasal Cannula is the first listed.
NCT00356668 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00356668 about?
NCT00356668 is a clinical study titled "Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure". The specific aims of this study are to evaluate the amount of high flow nasal cannula (HFNC) gas flow required to generate an equivalent positive distending pressure as that provided by nasal continuous positive airway pressure (NCPAP) of 6 cm H2O, assess the relationships between positive distendin...
What is the current status of trial NCT00356668?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 16 participants. The study started on 2006-07. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00356668?
The interventions under investigation include: High Flow Nasal Cannula (DEVICE).
Who is sponsoring clinical trial NCT00356668?
This trial is sponsored by Children's Hospitals and Clinics of Minnesota, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.